Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 16.35 is 52% below its 5-year average of 34.35, near the low end of its 5-year range (16.35–62.09).
As of the fiscal period ended Tuesday, June 30, 2026. 47.37% below its 12-month average of 31.06.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.35.
CURRENT RATIO
16.35
CURRENT RATIO AVG TTM
31.06
CURRENT RATIO AVG 3Y
38.45
CURRENT RATIO AVG 5Y
34.35
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-47.37%
CURRENT VS 3Y AVG
-57.48%
CURRENT VS 5Y AVG
-52.42%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+335.93%
vs the sector median at left
Janux Therapeutics, Inc.
Market Cap
$1.02B
Current Ratio
16.35
TTM Avg
31.06
3Y Avg
38.45
5Y Avg
34.35
Market Cap
$1.02B
Current Ratio
6.04
TTM Avg
6.28
3Y Avg
6.71
5Y Avg
10.27
Market Cap
$1.02B
Current Ratio
1.44
TTM Avg
1.13
3Y Avg
1.10
5Y Avg
1.10
Market Cap
$1.03B
Current Ratio
3.40
TTM Avg
1.85
3Y Avg
2.70
5Y Avg
2.88
Market Cap
$1.00B
Current Ratio
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$991.24M
Current Ratio
6.55
TTM Avg
7.96
3Y Avg
7.82
5Y Avg
9.82
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | $1.02B | 16.35 | 31.06 | 38.45 | 34.35 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | 6.04 | 6.28 | 6.71 | 10.27 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.44 | 1.13 | 1.10 | 1.10 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 3.40 | 1.85 | 2.70 | 2.88 |
| Immatics N.V. (IMTX)vs › | $1.01B | 7.54 | 10.49 | 6.85 | 5.34 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.00B | 8.42 | 11.89 | 15.48 | 17.00 |
| Vor Biopharma Inc. (VOR)vs › | $993.23M | 19.15 | 11.70 | 12.62 | 12.74 |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 0.83 | 2.23 | 2.80 | 3.02 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $991.24M | 6.55 | 7.96 | 7.82 | 9.82 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $980.66M | 15.08 | 22.50 | 27.08 | 27.08 |
Current Ratio
16.35
Quick Ratio
16.35
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 16.35 |
| 2026-03-31 | 17.01 |
| 2025-12-31 | 39.04 |
| 2025-09-30 | 35.86 |
| 2025-06-30 | 47.03 |
| 2025-03-31 | 58.47 |
| 2024-12-31 | 59.21 |
| 2024-09-30 | 38.80 |
| 2024-06-30 | 57.34 |
| 2024-03-31 | 62.09 |
| 2023-12-31 | 26.80 |
| 2023-09-30 | 24.55 |
| 2023-06-30 | 17.28 |
| 2023-03-31 | 19.95 |
| 2022-12-31 | 20.14 |
| 2022-09-30 | 21.08 |
| 2022-06-30 | 27.56 |
| 2022-03-31 | 29.14 |
| 2021-12-31 | 29.46 |
| 2021-09-30 | 31.24 |
| 2021-06-30 | 43.09 |
| 2021-03-31 | 10.36 |
| 2020-12-31 | 5.05 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
